Cargando…
A genotypic method for determining HIV-2 coreceptor usage enables epidemiological studies and clinical decision support
BACKGROUND: CCR5-coreceptor antagonists can be used for treating HIV-2 infected individuals. Before initiating treatment with coreceptor antagonists, viral coreceptor usage should be determined to ensure that the virus can use only the CCR5 coreceptor (R5) and cannot evade the drug by using the CXCR...
Autores principales: | Döring, Matthias, Borrego, Pedro, Büch, Joachim, Martins, Andreia, Friedrich, Georg, Camacho, Ricardo Jorge, Eberle, Josef, Kaiser, Rolf, Lengauer, Thomas, Taveira, Nuno, Pfeifer, Nico |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5168878/ https://www.ncbi.nlm.nih.gov/pubmed/27998283 http://dx.doi.org/10.1186/s12977-016-0320-7 |
Ejemplares similares
-
Association Between HIV-1 Coreceptor Usage and Resistance to Broadly Neutralizing Antibodies
por: Pfeifer, Nico, et al.
Publicado: (2014) -
Improving HIV coreceptor usage prediction in the clinic using hints from next-generation sequencing data
por: Pfeifer, Nico, et al.
Publicado: (2012) -
Analysis of Physicochemical and Structural Properties Determining HIV-1 Coreceptor Usage
por: Bozek, Katarzyna, et al.
Publicado: (2013) -
geno2pheno[ngs-freq]: a genotypic interpretation system for identifying viral drug resistance using next-generation sequencing data
por: Döring, Matthias, et al.
Publicado: (2018) -
Structural Descriptors of gp120 V3 Loop for the Prediction of HIV-1 Coreceptor Usage
por: Sander, Oliver, et al.
Publicado: (2007)